Ana Belo,  —

Recent Posts

• Lessons learned from my most recent sickle cell pain crisis
• SCD patients free of VOEs after treatment with gene-editing therapy
• Etavopivat may reduce VOC rate, increase hemoglobin in SCD
• Why it’s important to celebrate good care when we receive it
• Most patients free of vaso-occlusive crises for years after Casgevy dose
• The difficult reality of dealing with invisible sickle cell complications
• Most SCD patients given Lyfgenia in trials stay free of VOEs: New data
• How I cope with cold weather as someone with sickle cell disease
• Kanglin raises $20M to advance sickle cell gene therapy KL003
• Trial of gene-editing therapy into SCD’s cause opens in California